June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Botulinum Toxin-Augmented Strabismus Surgery versus Conventional Surgery in the Treatment of Large-Angle Infantile Esotropia
Author Affiliations & Notes
  • Aubrey Gilbert
    Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston, MA
    Ophthalmology, Boston Children’s Hospital and Harvard Medical School, Boston, MA
  • Michael J. Wan
    Ophthalmology, Boston Children’s Hospital and Harvard Medical School, Boston, MA
  • Melanie Kazlas
    Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston, MA
    Ophthalmology, Boston Children’s Hospital and Harvard Medical School, Boston, MA
  • Carolyn Wu
    Ophthalmology, Boston Children’s Hospital and Harvard Medical School, Boston, MA
  • David G Hunter
    Ophthalmology, Boston Children’s Hospital and Harvard Medical School, Boston, MA
  • Iason Mantagos
    Ophthalmology, Boston Children’s Hospital and Harvard Medical School, Boston, MA
  • Ankoor Shah
    Ophthalmology, Boston Children’s Hospital and Harvard Medical School, Boston, MA
  • Footnotes
    Commercial Relationships Aubrey Gilbert, None; Michael Wan, None; Melanie Kazlas, None; Carolyn Wu, None; David Hunter, None; Iason Mantagos, None; Ankoor Shah, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 5217. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Aubrey Gilbert, Michael J. Wan, Melanie Kazlas, Carolyn Wu, David G Hunter, Iason Mantagos, Ankoor Shah; Botulinum Toxin-Augmented Strabismus Surgery versus Conventional Surgery in the Treatment of Large-Angle Infantile Esotropia. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):5217.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: The treatment of large-angle infantile esotropia remains a challenge. Surgical treatment traditionally has involved either three-muscle surgery or supra-maximal medial rectus recessions, but both methods have significant drawbacks including risk of over- or undercorrection. An alternative is to use botulinum toxin to weaken the medial rectus muscles, but multiple treatments are often required and the success rate for large deviations is poor. It has been suggested that the best approach may be to combine these treatments. No previous study has directly compared botulinum toxin-augmented surgery to conventional surgery alone.

Methods: A retrospective, comparative study was completed evaluating baseline characteristics and outcomes of consecutive patients with large-angle infantile esotropia (55 prism diopters(Δ) or greater) who underwent either conventional or botulinum toxin-augmented strabismus surgery. The primary outcome measure was post-operative deviation and need for retreatment within one year of initial intervention. Success was defined as a deviation <10Δ and no retreatment at 1 year after the initial intervention.

Results: The record review identified 38 patients meeting inclusion criteria, of whom 14 had been treated with botulinum toxin-augmented surgery and 24 with bilateral medial rectus recessions. Prior to surgery, the augmented group had a larger median angle of deviation (65 versus 60Δ, p = 0.006) and less recession of the medial rectus muscles was performed (5.5 versus 6.0 mm, p = 0.005). The augmented group had greater success at 1 year (70% versus 30%, p = 0.035). The augmented group also had a significantly smaller median angle of deviation at 1 year (0 versus 18Δ, p = 0.026). There were no serious complications in either group.

Conclusions: Botulinum toxin can significantly augment the effect of medial rectus recessions and improve the success of strabismus surgery in patients with large-angle infantile esotropia.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×